Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: A randomized comparison of efficacy and safety in subjects with scalp psoriasis
- 1 February 2005
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 16 (1) , 31-36
Abstract
Background: Scalp involvement in psoriatic patients represents a common issue. Treatment of the hairy skin requires adequate pharmaceutical formulations; hence, a new specific shampoo formulation of clobetasol propionate 0.05% was developed by Galderma R&D, Inc. Methods: For this multicenter, randomized, investigator‐masked, parallel group study, 151 subjects with moderate to severe scalp psoriasis were randomized to 4 weeks of treatment with clobetasol propionate shampoo or calcipotriol solution. Results: Clobetasol propionate demonstrated significantly superior efficacy to calcipotriol solution (total severity score: mean difference 0.51, 95% CI 0.05–0.97, p = 0.028; global severity score: mean difference 0.43, 95% CI 0.08–0.78, p = 0.016). Adverse events were more common in the calcipotriol group than in the clobetasol propionate shampoo group. Telangiectasia and skin atrophy did not differ significantly between treatments; however, a burning sensation was significantly more common in the calcipotriol solution group. Conclusions: Short contact therapy of scalp psoriasis with this new shampoo formulation of clobetasol propionate was significantly more effective and better tolerated than calcipotriol solution for the treatment of scalp psoriasis.Keywords
This publication has 15 references indexed in Scilit:
- Topical preparations for the treatment of psoriasis: a systematic reviewBritish Journal of Dermatology, 2002
- Calcipotriol OintmentAmerican Journal of Clinical Dermatology, 2001
- Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacyBritish Journal of Dermatology, 1998
- POPULATION-BASED EPIDEMIOLOGIC STUDY OF PSORIASIS WITH EMPHASIS ON QUALITY OF LIFE ASSESSMENTDermatologic Clinics, 1996
- Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasisClinical Therapeutics, 1995
- Comparative effects of calcipotriol solution (50 μg/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasisBritish Journal of Dermatology, 1994
- Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalpBritish Journal of Dermatology, 1994
- Topical clobetasol-17-propionate: Review of its clinical efficacy and safetyJournal of the American Academy of Dermatology, 1986
- Clobetasol Propionate Versus Fluocinonide Creams in Psoriasis and EczemaInternational Journal of Dermatology, 1985
- The Natural History of Psoriasis in 5,600 PatientsDermatology, 1974